Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid.

Slides:



Advertisements
Similar presentations
Protecting the heart and the kidney: Implications from the SHARP trial Dr. Christina Reith University of Oxford United Kingdom.
Advertisements

HPS2-THRIVE: Randomized placebo-controlled trial of ER niacin and laropiprant in 25,673 patients with pre-existing cardiovascular disease. Jane Armitage.
HPS: Heart Protection Study Purpose To determine whether simvastatin reduces mortality and vascular events in patients with and without coronary disease,
C. Baigent, et al. on behalf of the SHARP Investigators Lancet 2011;Epub 9 June.
LIPID: Long-term Intervention with Pravastatin in Ischemic Disease Purpose To determine whether pravastatin will reduce coronary mortality and morbidity.
4S: Scandinavian Simvastatin Survival Study
Date of download: 2/26/2013 Copyright © 2012 American Medical Association. All rights reserved. From: Incidence of Breast Cancer With Distant Involvement.
Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.
Fat or Low-fat? Anwar T. Merchant ScD, MPH, DMD Department of Epidemiology and Biostatistics.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Adjuvant Chemotherapy With Gemcitabine and Long-term.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of a Fixed-Dose Combination Strategy on Adherence.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Aspirin for the Prevention of Cardiovascular Events.
Date of download: 5/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Elective Intra-aortic Balloon Counterpulsation During.
Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Estrogen Plus Progestin and Breast Cancer Incidence.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Varespladib and Cardiovascular Events in Patients.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Menopausal Hormone Therapy and Health Outcomes During.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Diagnoses and Timing of 30-Day Readmissions After.
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Increasing Doses of Saw Palmetto Extract.
Date of download: 6/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Major Lipids, Apolipoproteins, and Risk of Vascular.
Date of download: 6/21/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Episodic Physical and Sexual Activity.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: BNP-Guided vs Symptom-Guided Heart Failure Therapy:
Date of download: 6/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cardiorespiratory Fitness as a Quantitative Predictor.
Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Decline in Estimated Glomerular Filtration Rate and.
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Oral Iron Supplementation After Blood Donation: A.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of High vs Low Glycemic Index of Dietary Carbohydrate.
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Corticosteroids in the Treatment of Severe Sepsis.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Reduced-Function CYP2C19 Genotype and Risk of Adverse.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Structured Physical Activity on Prevention.
Date of download: 9/18/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Randomized Trial of Estrogen Plus Progestin for Secondary.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Naturally Random Allocation to Lower Low-Density.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Public Reporting for Percutaneous.
Date of download: 9/19/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Glycated Hemoglobin Measurement and Prediction of.
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association of Apolipoprotein E Genotypes With Lipid.
Date of download: 11/13/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Stereotactic Radiosurgery Plus Whole-Brain Radiation.
Volume 376, Issue 9753, Pages (November 2010)
Copyright © 2013 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Arch Intern Med. 2004;164(13): doi: /archinte Figure Legend:
Copyright © 2015 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2010 American Medical Association. All rights reserved.
Copyright © 2001 American Medical Association. All rights reserved.
Copyright © 2003 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2001 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2000 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2013 American Medical Association. All rights reserved.
Copyright © 2003 American Medical Association. All rights reserved.
Copyright © 2002 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
SEARCH Collaborative Group. Lancet 2010;epub 9 Nov
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Jane Armitage on behalf of the HPS2-THRIVE Collaborative Group
Baseline characteristics of HPS participants by prior diabetes
Volume 376, Issue 9753, Pages (November 2010)
Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised.
Presentation transcript:

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B 12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors: A Randomized Trial JAMA. 2010;303(24): doi: /jama Numbers lost to follow-up relate to those without information to the end of the scheduled treatment period on mortality (as well as morbidity) and on morbidity alone. For the reasons given for stopping study tablets, nonstudy statin was started in 92% of the participants who were advised to stop for medical reasons. “Personal reasons” excludes discontinuations attributed to medical reasons. More than 1 reason could be reported. Figure Legend:

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B 12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors: A Randomized Trial JAMA. 2010;303(24): doi: /jama Analyses are of the numbers of participants having a first event of each type during follow-up (with nonfatal and fatal events considered separately), so there is some nonadditivity between different types of event. Risk ratios compare outcome among participants allocated folic acid and vitamin B 12 to that among those allocated placebo. Data markers are approximately proportional to the numbers of events in each subdivision. CI indicates confidence interval; MI, myocardial infarction; CHD, coronary heart disease. Figure Legend:

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B 12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors: A Randomized Trial JAMA. 2010;303(24): doi: /jama Analyses are of numbers of participants having a first event during each year of follow-up and of those still at risk of a first event at the start of each year. CI indicates confidence interval. Figure Legend:

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B 12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors: A Randomized Trial JAMA. 2010;303(24): doi: /jama P values for χ 2 1 tests are given for heterogeneity between risk ratios within dichotomous categories and for trend within other categories (except for prior disease categories since there is some overlap between them). Cholesterol categories relate to measured values at the randomization visit after all participants had been taking 20 mg simvastatin daily for 2 months during the prerandomization run-in phase. The data analysis plan prespecified that blood homocysteine, vitamin, and cholesterol values would be used to subdivide participants into 3 similar-sized groups. GFR MDRD indicates glomerular filtration rate estimated using the Modification of Diet in Renal Disease equation. CI indicates confidence interval; MI, myocardial infarction; CHD, coronary heart disease; LDL, low-density lipoprotein. Figure Legend:

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B 12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors: A Randomized Trial JAMA. 2010;303(24): doi: /jama CHD indicates coronary heart disease; CI, confidence interval; MI, myocardial infarction. Figure Legend:

Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B 12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors: A Randomized Trial JAMA. 2010;303(24): doi: /jama Analyses are of the numbers of participants developing cancer at each site (excluding recurrences or new cancers at the same site), so there is some nonadditivity between cancers at different sites. “Connective tissue” excludes nonmelanoma skin cancers, which are given separately. CI indicates confidence interval. Figure Legend: